Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biopsy, Fine-Needle | 6 | 2024 | 1110 | 1.280 |
Why?
|
| Congo Red | 1 | 2024 | 48 | 0.940 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2024 | 935 | 0.930 |
Why?
|
| Carcinoma, Signet Ring Cell | 2 | 2020 | 82 | 0.830 |
Why?
|
| Rhabdoid Tumor | 1 | 2024 | 210 | 0.790 |
Why?
|
| Sarcoma, Kaposi | 1 | 2024 | 374 | 0.740 |
Why?
|
| Staining and Labeling | 1 | 2024 | 1083 | 0.680 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 1 | 2020 | 63 | 0.660 |
Why?
|
| Amyloid | 1 | 2024 | 839 | 0.650 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2019 | 81 | 0.640 |
Why?
|
| Carcinoma, Papillary, Follicular | 1 | 2018 | 60 | 0.620 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2022 | 304 | 0.600 |
Why?
|
| Observer Variation | 1 | 2024 | 2599 | 0.600 |
Why?
|
| PAX2 Transcription Factor | 1 | 2017 | 86 | 0.590 |
Why?
|
| Prostate | 5 | 2024 | 1757 | 0.590 |
Why?
|
| Prostatic Neoplasms | 6 | 2024 | 11057 | 0.580 |
Why?
|
| Pleural Effusion | 1 | 2020 | 342 | 0.580 |
Why?
|
| Meningioma | 1 | 2024 | 1217 | 0.490 |
Why?
|
| Meningeal Neoplasms | 1 | 2024 | 1247 | 0.480 |
Why?
|
| Lung Transplantation | 1 | 2024 | 1306 | 0.480 |
Why?
|
| Teratoma | 1 | 2017 | 402 | 0.450 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2017 | 517 | 0.420 |
Why?
|
| Adipose Tissue | 1 | 2024 | 3298 | 0.400 |
Why?
|
| Carcinoma in Situ | 1 | 2017 | 793 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 1403 | 0.370 |
Why?
|
| Adenoma | 1 | 2020 | 2147 | 0.330 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 1356 | 0.310 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3608 | 0.290 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 2326 | 0.250 |
Why?
|
| Prostatectomy | 2 | 2024 | 1821 | 0.240 |
Why?
|
| Precancerous Conditions | 2 | 2023 | 977 | 0.230 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 13268 | 0.200 |
Why?
|
| Coloring Agents | 1 | 2024 | 559 | 0.190 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 6323 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 4019 | 0.190 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2024 | 454 | 0.180 |
Why?
|
| Salivary Glands | 1 | 2022 | 229 | 0.180 |
Why?
|
| Synaptophysin | 1 | 2020 | 138 | 0.170 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 4872 | 0.170 |
Why?
|
| Adrenal Glands | 1 | 2022 | 551 | 0.160 |
Why?
|
| Chromogranins | 1 | 2020 | 160 | 0.160 |
Why?
|
| Prostatic Diseases | 1 | 2019 | 57 | 0.160 |
Why?
|
| Pathology | 1 | 2021 | 270 | 0.160 |
Why?
|
| Computer-Assisted Instruction | 1 | 2021 | 362 | 0.150 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2020 | 617 | 0.150 |
Why?
|
| Amyloidosis | 1 | 2024 | 817 | 0.140 |
Why?
|
| Endometrial Hyperplasia | 1 | 2017 | 97 | 0.140 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 327 | 0.130 |
Why?
|
| Humans | 17 | 2024 | 757566 | 0.120 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2017 | 276 | 0.120 |
Why?
|
| Atrophy | 1 | 2019 | 1627 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2024 | 2800 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 995 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2017 | 764 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 1 | 2022 | 2456 | 0.110 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2021 | 1065 | 0.100 |
Why?
|
| Biopsy | 1 | 2024 | 6757 | 0.100 |
Why?
|
| Male | 10 | 2024 | 358180 | 0.100 |
Why?
|
| Female | 7 | 2024 | 389943 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4886 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2024 | 2881 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2022 | 79984 | 0.080 |
Why?
|
| Adult | 5 | 2024 | 219725 | 0.080 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 3510 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3839 | 0.080 |
Why?
|
| Aged | 4 | 2024 | 167890 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4350 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 20037 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8503 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12951 | 0.060 |
Why?
|
| Lung | 1 | 2020 | 9973 | 0.050 |
Why?
|
| Prognosis | 1 | 2022 | 29488 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2022 | 23816 | 0.050 |
Why?
|
| Attitude to Computers | 1 | 2021 | 195 | 0.050 |
Why?
|
| Young Adult | 2 | 2017 | 58755 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2023 | 1900 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 219192 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10709 | 0.040 |
Why?
|
| Prostatitis | 1 | 2019 | 102 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 856 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2023 | 2506 | 0.040 |
Why?
|
| Telomere | 1 | 2023 | 931 | 0.040 |
Why?
|
| Animals | 4 | 2023 | 167718 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2023 | 2012 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 58558 | 0.020 |
Why?
|
| Mitochondria | 1 | 2023 | 3583 | 0.020 |
Why?
|
| Mice | 3 | 2023 | 81066 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9514 | 0.020 |
Why?
|
| Child | 1 | 2017 | 79782 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 87819 | 0.020 |
Why?
|
| Students, Medical | 1 | 2021 | 1926 | 0.020 |
Why?
|
| Curriculum | 1 | 2021 | 3715 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2019 | 9263 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18114 | 0.010 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_